Resveratrol Reduces Platelet Storage Lesion by Preventing Free Mitochondrial DNA (mtDNA) Accumulation in Platelet Concentrates During Storage

Overview

Journal J Thromb Thrombolysis

Specialty Cardiology & Vascular Diseases

Date 2023 May 22

PMID 37213065

Authors

Kamand Haeri

Shahram Samiee

Smerdis Hajati

Mohammadreza Deyhim

Affiliations

Soon will be listed here.

Abstract

Platelet activation and mitochondrial damage are among the crucial events leading to the quality reduction of platelet concentrates (PCs) during preparation and storage, called platelet storage lesion. Platelet activation results in the clearance of transfused platelets. Oxidative stress and platelet activation trigger mitochondrial DNA (mtDNA) release into the extracellular milieu which is associated with adverse transfusion reactions. Therefore, we aimed to investigate the effects of resveratrol, an antioxidant polyphenol, on platelet activation markers and mtDNA release. Ten PCs were divided equally into two bags each, one of them was allocated to the control group (n = 10) and another to the case group (resveratrol-treated, n = 10). Free mtDNA level and CD62P (P-selectin) expression level were measured by absolute quantification Real-Time PCR, and flow cytometry on days 0 (the receiving day), 3, 5, and 7 of storage respectively. Moreover, Lactate dehydrogenase (LDH) enzyme activity, pH, platelet count, mean platelet volume (MPV), and platelet distribution width (PDW) were assessed as well. Treatment of PCs with resveratrol can significantly decrease mtDNA release during storage compared to the control. In addition, platelet activation was significantly mitigated. We also observed significantly lower MPV, PDW, and LDH activity in resveratrol-treated PCs compared to the control group on days 3, 5, and 7. Furthermore, resveratrol maintained the pH of PCs on day 7. Resveratrol diminished free mtDNA and maintained biochemical parameters in PCs, possibly by reducing platelet activation. Therefore, resveratrol might be a possible additive solution for improving the quality of stored PCs.

Citing Articles

Platelet Storage-Problems, Improvements, and New Perspectives.

Trochanowska-Pauk N, Walski T, Bohara R, Mikolas J, Kubica K Int J Mol Sci. 2024; 25(14).

PMID: 39063021 PMC: 11277025. DOI: 10.3390/ijms25147779.

References

Rinder H, Murphy M, Mitchell J, Stocks J, Ault K, HILLMAN R . Progressive platelet activation with storage: evidence for shortened survival of activated platelets after transfusion. Transfusion. 1991; 31(5):409-14. DOI: 10.1046/j.1537-2995.1991.31591263195.x. View

Triulzi D, Kickler T, Braine H . Detection and significance of alpha granule membrane protein 140 expression on platelets collected by apheresis. Transfusion. 1992; 32(6):529-33. DOI: 10.1046/j.1537-2995.1992.32692367196.x. View

Larsen E, Celi A, Gilbert G, Furie B, Erban J, Bonfanti R . PADGEM protein: a receptor that mediates the interaction of activated platelets with neutrophils and monocytes. Cell. 1989; 59(2):305-12. DOI: 10.1016/0092-8674(89)90292-4. View

Hamburger S, McEver R . GMP-140 mediates adhesion of stimulated platelets to neutrophils. Blood. 1990; 75(3):550-4. View

Marcoux G, Duchez A, Rousseau M, Levesque T, Boudreau L, Thibault L . Microparticle and mitochondrial release during extended storage of different types of platelet concentrates. Platelets. 2016; 28(3):272-280. DOI: 10.1080/09537104.2016.1218455. View

Cognasse F, Aloui C, Nguyen K, Hamzeh-Cognasse H, Fagan J, Arthaud C . Platelet components associated with adverse reactions: predictive value of mitochondrial DNA relative to biological response modifiers. Transfusion. 2015; 56(2):497-504. DOI: 10.1111/trf.13373. View

Boudreau L, Duchez A, Cloutier N, Soulet D, Martin N, Bollinger J . Platelets release mitochondria serving as substrate for bactericidal group IIA-secreted phospholipase A2 to promote inflammation. Blood. 2014; 124(14):2173-83. PMC: 4260364. DOI: 10.1182/blood-2014-05-573543. View

Yasui K, Matsuyama N, Kuroishi A, Tani Y, Furuta R, Hirayama F . Mitochondrial damage-associated molecular patterns as potential proinflammatory mediators in post-platelet transfusion adverse effects. Transfusion. 2016; 56(5):1201-12. DOI: 10.1111/trf.13535. View

Marcoux G, Magron A, Sut C, Laroche A, Laradi S, Hamzeh-Cognasse H . Platelet-derived extracellular vesicles convey mitochondrial DAMPs in platelet concentrates and their levels are associated with adverse reactions. Transfusion. 2019; 59(7):2403-2414. DOI: 10.1111/trf.15300. View

10.

Manach C, Williamson G, Morand C, Scalbert A, Remesy C . Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies. Am J Clin Nutr. 2005; 81(1 Suppl):230S-242S. DOI: 10.1093/ajcn/81.1.230S. View

11.

Bechmann L, Zahn D, Gieseler R, Fingas C, Marquitan G, Jochum C . Resveratrol amplifies profibrogenic effects of free fatty acids on human hepatic stellate cells. Hepatol Res. 2009; 39(6):601-8. PMC: 2893585. DOI: 10.1111/j.1872-034X.2008.00485.x. View

12.

Shen M, Hsiao G, Liu C, Fong T, Lin K, Chou D . Inhibitory mechanisms of resveratrol in platelet activation: pivotal roles of p38 MAPK and NO/cyclic GMP. Br J Haematol. 2007; 139(3):475-85. DOI: 10.1111/j.1365-2141.2007.06788.x. View

13.

Olas B, Zbikowska H, Wachowicz B, Krajewski T, Buczynski A, Magnuszewska A . Inhibitory effect of resveratrol on free radical generation in blood platelets. Acta Biochim Pol. 2000; 46(4):961-6. View

14.

Wu Y, Zhou Y, Gao H, Wang Y, Cheng Q, Jian S . LYAR Promotes Colorectal Cancer Progression by Upregulating Expression and Fatty Acid Metabolism. Oxid Med Cell Longev. 2022; 2021:9979707. PMC: 8769847. DOI: 10.1155/2021/9979707. View

15.

Seghatchian J, Krailadsiri P . The platelet storage lesion. Transfus Med Rev. 1997; 11(2):130-44. DOI: 10.1053/tm.1997.0110130. View

16.

Reza Deyhim M, Mesbah-Namin S, Yari F, Taghikhani M, Amirizadeh N . L-carnitine effectively improves the metabolism and quality of platelet concentrates during storage. Ann Hematol. 2014; 94(4):671-80. DOI: 10.1007/s00277-014-2243-5. View

17.

Di Meo S, Reed T, Venditti P, Victor V . Harmful and Beneficial Role of ROS. Oxid Med Cell Longev. 2016; 2016:7909186. PMC: 5080479. DOI: 10.1155/2016/7909186. View

18.

Lee J, Giordano S, Zhang J . Autophagy, mitochondria and oxidative stress: cross-talk and redox signalling. Biochem J. 2011; 441(2):523-40. PMC: 3258656. DOI: 10.1042/BJ20111451. View

19.

Lenaz G, Bovina C, DAurelio M, Fato R, Formiggini G, Genova M . Role of mitochondria in oxidative stress and aging. Ann N Y Acad Sci. 2002; 959:199-213. DOI: 10.1111/j.1749-6632.2002.tb02094.x. View

20.

Bagheri S, Samiee S, Zarif M, Reza Deyhim M . L-carnitine modulates free mitochondrial DNA DAMPs and platelet storage lesions during storage of platelet concentrates. J Thromb Thrombolysis. 2022; 55(1):60-66. DOI: 10.1007/s11239-022-02725-2. View